Powered by Xconomy, November 2019’s What’s Next in Neuroscience Therapies event brought together scientists, entrepreneurs and biotech executives at the Hyatt Regency San Francisco to discuss their work developing next-generation neuroscience therapies and technologies in areas such as spinal-cord injuries, precision mental health, dementia and Alzheimer’s disease.

Modern pharmacies have lost the personal touch that ma and pa shops once had as they grapple with a growing patient volume. Pharmaceutical executives would be wise to abandon their struggling system and adopt an entrepreneurial mindset.